Solcitinib
Solcitinib is an orally active, competitive, potent, selective JAK1 inhibitor, with an IC50 of 9.8 nM, and 11-, 55- and 23-fold selectivity over JAK2, JAK3 and TYK2, respectively; Solcitinib is used in the research of moderate-to-severe plaque-type psoriasis.
Product Specifications
CAS Number
1206163-45-2
Product Name Alternative
GSK-2586184; GLPG-0778
UNSPSC
12352005
Hazard Statement
H302
Target
JAK
Type
Reference compound
Related Pathways
Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/Solcitinib.html
Purity
99.51
Solubility
DMSO : 16.67 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(C1CC1)NC2=NN3C(C4=CC=C(C(N5CC(C)(C)C5)=O)C=C4)=CC=CC3=N2
Molecular Formula
C22H23N5O2
Molecular Weight
389.45
Precautions
H302
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
JAK1
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
O,O-Bis(4-chlorophenyl) Phosphorochloridothioate
14-3-3 zeta (YWHAZ) (NM_001135702) Human Over-expression Lysate
